C4- CFT7455-1102 - Clinical Trial
Who Can Participate in the Study?
Age Group
Adults
Study Details
Full Title
A Phase 1b, Open-Label, Multicenter Study to Evaluate the Safety and Preliminary Efficacy of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma
Principal Investigator
Cristina Gasparetto, MD
Cellular Therapy Specialist
Protocol Number
IRB:
PRO00119697
NCT:
NCT07280013
Phase
Phase I
ClinicalTrials.gov
View on ClinicalTrials.gov
Enrollment Status
Open for Enrollment